Publications:

Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab.

Mabs

Courtois, Fabienne F; Agrawal, Neeraj J NJ; Lauer, Timothy M TM; Trout, Bernhardt L BL

Publication Date: 2016

Variant appearance in text: VEGF-A: L185N

PubMed Link: 26514585

Variant Present in the following documents:

• Main text

View BVdb publication page